Table 3. Univariate and multivariate Cox regression analyses of different parameters of progression-free interval in liver hepatocellular carcinoma.
Characteristics | Total (N) | Univariate analysis | Multivariate analysis | |||
Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value | |||
T stage | 370 | |||||
T1 | 183 | |||||
T2 | 94 | 2.017 (1.409–2.888) | <0.001 | 1.100 (0.694–1.742) | 0.686 | |
T3 and T4 | 93 | 2.798 (1.969–3.975) | <0.001 | 0.895 (0.212–3.785) | 0.880 | |
N stage | 258 | |||||
N0 | 254 | |||||
N1 | 4 | 1.370 (0.338–5.552) | 0.659 | |||
M stage | 272 | |||||
M0 | 268 | |||||
M1 | 4 | 3.476 (1.091–11.076) | 0.035 | 1.462 (0.447–4.782) | 0.530 | |
Pathologic stage | 349 | |||||
Stage I and Stage II | 259 | |||||
Stage III and Stage IV | 90 | 2.201 (1.591–3.046) | <0.001 | 2.043 (0.488–8.555) | 0.328 | |
Tumour status | 354 | |||||
Tumour free | 202 | |||||
With tumour | 152 | 11.342 (7.567–17.000) | <0.001 | 15.140 (9.082–25.237) | <0.001 | |
CCDC50 | 373 | 2.303 (0.186–28.565) | 0.516 |